Financials in USD. Standardized financial statements.
A compact view of how CollPlant Biotechnologies Ltd. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.37M | $515,000 | $10.96M | $299,000 | $15.64M | $6.14M | $2.32M | $4.79M | $479,917 | $75,911 |
| Revenue Growth? | +360.4% | -95.3% | +3565.2% | -98.1% | +154.9% | +164.8% | -51.6% | +897.8% | +532.2% | 0.0% |
| Cost of Revenue? | $1.75M | $2.66M | $3.09M | $1.48M | $2.00M | $3.46M | $1.88M | $1.90M | $306,090 | $225,072 |
| Gross Profit? | $624,000 | -$2.15M | $7.87M | -$1.18M | $13.64M | $2.68M | $439,000 | $3.11M | $157,632 | -$149,006 |
| Gross Margin? | +26.3% | -417.1% | +71.8% | -393.6% | +87.2% | +43.7% | +18.9% | +65.0% | +32.8% | -196.3% |
| Operating Expenses? | $12.11M | $15.10M | $15.38M | $15.92M | $13.57M | $8.28M | $8.07M | $7.68M | $6.72M | $10.26M |
| Operating Income? | -$11.48M | -$17.25M | -$7.51M | -$17.10M | $65,000 | -$5.60M | -$7.63M | -$4.07M | -$5.97M | -$7.16M |
| EBITDA? | -$10.57M | -$15.55M | -$5.91M | -$15.81M | $1.05M | -$5.08M | -$10.55M | -$5.88M | -$5.41M | -$7.03M |
| Income Before Tax | -$11.49M | -$16.61M | -$7.02M | -$16.93M | $237,000 | -$5.77M | -$11.16M | -$3.69M | -$6.01M | -$7.25M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.96M | $28,442 | $0 |
| Net Income? | -$11.49M | -$16.61M | -$7.02M | -$16.93M | $237,000 | -$5.77M | -$11.16M | -$6.25M | -$5.80M | -$7.27M |
| EPS? | $-0.94 | $-1.45 | $-0.62 | $-1.52 | $0.04 | $-0.84 | $-2.95 | $-1.43 | $-2.27 | $-3.60 |
| Diluted EPS? | $-0.94 | $-1.45 | $-0.62 | $-1.52 | $0.03 | $-0.84 | $-2.95 | $-1.43 | $-2.27 | $-3.60 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality